Facebook
Twitter
Telegram
Report an ErrorGenMark Diagnostics, Inc. Financial Ratios 2011-2024 | GNMK
Annual Financial Ratios GenMark Diagnostics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-50.0 | -6.7 | -7.1 | -4.4 | -10.3 | -5.3 | -13.9 | -13.1 | -12.6 | -3.1 |
P/S |
5.4 | 3.6 | 5.1 | 5.2 | 10.6 | 5.7 | 17.4 | 16.1 | 13.6 | 14.9 |
EV/EBITDA |
-243.8 | -9.9 | -8.9 | -5.0 | -11.7 | -5.2 | -13.6 | -12.5 | -11.0 | -2.2 |
PEG |
0.76 | 0.68 | 0.29 | -0.84 | -0.69 | -0.7 | 6.61 | -1.0 | 0.3 | 0.14 |
P/B |
9.9 | 26.0 | 10.8 | 3.9 | 13.7 | 4.6 | 6.8 | 4.0 | 4.9 | 2.4 |
P/CF |
-80.1 | -8.6 | -10.3 | -4.6 | -11.8 | -6.2 | -14.9 | -15.2 | -13.3 | -3.5 |
ROE % |
-19.79 | -389.30 | -150.54 | -87.83 | -132.63 | -86.83 | -49.04 | -30.82 | -39.16 | -78.25 |
ROA % |
-8.34 | -42.48 | -54.31 | -50.88 | -63.00 | -59.71 | -41.60 | -27.63 | -32.50 | -62.77 |
ROCE % |
-6.16 | -47.98 | -65.72 | -63.44 | -90.87 | -69.14 | -49.02 | -31.28 | -37.20 | -75.03 |
DSO |
44.2 | 69.5 | 59.5 | 74.2 | 67.0 | 63.4 | 58.3 | 38.1 | 56.9 | 80.0 |
DIO |
75.1 | 69.4 | 72.9 | 122.9 | 122.9 | 72.8 | 59.4 | 48.3 | 62.5 | 127.5 |
DPO |
81.3 | 75.2 | 70.4 | 125.4 | 161.2 | 104.3 | 96.4 | 88.7 | 76.7 | 70.6 |
All numbers in USD currency